Pacific Biosciences of California, Inc. (PACB)

PACB Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	180.21	325.39	461.23	82.45	29.93
Short-Term Investments	451.51	447.23	583.68	237.2	19.47
Cash & Cash Equivalents	631.72	772.62	1,045	319.65	49.4
Cash Growth	-18.24%	-26.06%	226.89%	547.08%	-51.74%
Receivables	36.62	18.79	24.24	16.84	15.27
Inventory	56.68	50.38	24.6	14.23	13.31
Other Current Assets	17.04	10.29	7.39	4.87	3.07
Total Current Assets	742.05	852.07	1,101	355.59	81.05
Property, Plant & Equipment	69.03	81.34	79.12	54.85	62.9
Long-Term Investments	2.42	2.92	4.59	3.5	4
Goodwill and Intangibles	919.25	820.22	820.95	0	0
Other Long-Term Assets	13.27	10.53	1.17	0.04	0.04
Total Long-Term Assets	1,004	915.01	905.84	58.39	66.94
Total Assets	1,746	1,767	2,007	413.98	147.99
Accounts Payable	15.06	12.03	11	3.58	8.37
Deferred Revenue	21.87	32.29	36.03	10.29	9.56
Current Debt	9.59	8.89	7.71	4.33	19.71
Other Current Liabilities	48.5	210.13	16.97	20.3	11.52
Total Current Liabilities	95.03	263.34	71.71	38.5	49.15
Long-Term Debt	923.85	937.75	946.04	37.67	41.96
Other Long-Term Liabilities	25.83	3.09	198.24	2.32	1.95
Total Long-Term Liabilities	949.68	940.85	1,144	39.99	43.92
Total Liabilities	1,045	1,204	1,216	78.49	93.07
Total Debt	933.44	946.64	953.75	42	61.67
Debt Growth	-1.39%	-0.75%	2170.88%	-31.90%	320.71%
Retained Earnings	-1,839.08	-1,532.34	-1,218.09	-1,036.87	-1,066.24
Comprehensive Income	0.22	-4.77	-1.09	0.09	0.01
Shareholders' Equity	701.3	562.9	790.99	335.49	54.92
Net Cash / Debt	-301.72	-174.02	91.15	277.65	-12.27
Net Cash / Debt Growth	-	-	-67.17%	-	-
Net Cash Per Share	-1.19	-0.77	0.45	1.59	-0.08
Working Capital	647.02	588.74	1,029	317.09	31.89
Book Value Per Share	2.77	2.51	3.88	2.03	0.36

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).